Hydrazine hydrate (1:1) → N-(3-(hydrazinecarbonyl)-4-methylthiophen-2-yl)-2-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetamide
反応式
O.[NH2:2][NH2:3].[CH3:4][C:5]1[C:6]([C:25](OC)=[O:26])=[C:7]([NH:10][C:11](=[O:24])[CH2:12][N:13]2[C:22]3[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=3)[CH2:16][CH2:15][C:14]2=[O:23])[S:8][CH:9]=1>C(O)C.[Cl-].[Na+].O>[NH:2]([C:25]([C:6]1[C:5]([CH3:4])=[CH:9][S:8][C:7]=1[NH:10][C:11](=[O:24])[CH2:12][N:13]1[C:22]2[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=2)[CH2:16][CH2:15][C:14]1=[O:23])=[O:26])[NH2:3]参加物
5
反応物 2
生成物 1
試薬・触媒・溶媒 2
反応条件
- 温度
- 50 °C
実験手順
Hydrazine monohydrate (0.059 mL, 1.23 mmol) was added to a solution of methyl 4-methyl-2-(2-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetamido)thiophene-3-carboxylate (221 mg, 0.616 mmol) in ethanol (2 mL) and the resulting solution was stirred at 50° C. for 24 h. The mixture was diluted with brine and extracted with ethyl acetate. The organic phase was separated, dried (Na2SO4), filtered, concentrated under vacuum to give N-(3-(hydrazinecarbonyl)-4-methylthiophen-2-yl)-2-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetamide (174 mg, 0.485 mmol, 79%). Retention time (min)=1.435, method [1], MS (ESI) 359.1 (M+H).
後処理
- extractionextracted with ethyl acetate
- customThe organic phase was separated
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated under vacuum
出典と根拠
- ORDレコード
- ord-0709b6f386b44d048348346697e9861b
- 出典データセット
- uspto-grants-2013_05
- 特許番号
- US08450363B2
反応ノート
読み込み中…